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Abstract 
BACKGROUND: Insulin-like growth factor 1 (IGF-1) is one of the essential intrauterine hormonal mediators of 
growth, and its serum values are often low after preterm delivery. 
AIM: To evaluate the influence of immediate breast milk feeding on serum IGF-1 in preterm newborns. 
SUBJECTS AND METHODS: This prospective, observational cohort study included 60 premature infants born < 
32 weeks of gestation, divided into group A and B regarding breastfeeding or formula feeding. Growth 
measurements were taken at birth. The standard deviation of each measurement was calculated. Serum IGF-I 
was measured one day postnatal and at a time equivalent to 40 weeks of gestation. 
RESULTS: Significant higher level of mean serum IGF-1 was detected in group A than B at postnatal age 
equivalent to 40 weeks of gestation. In group A, the higher significant level was detected in mean serum IGF-1 at 
an age equivalent to 40 weeks of gestation than at birth (25.21 ± 6.69 and 20.13 ± 5.46 p < 0.05). Multiple linear 
regression analysis showed that high birth weight, increased age of gestation and breastfeeding were correlated 
to the elevated serum level of IGF-1 at a postnatal age corresponding to 40 weeks gestational age. 
CONCLUSION: Immediate breast milk feeding was accompanied by elevated IGF-1 in the serum of preterm 
infants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
IGF-1 is an anabolic hormone with mitogenic, 
differentiating, antiapoptotic and metabolic effects [1]. 
A plethora of genetic and experimental researches 
suggest that IGF-1 is an essential factor of intrauterine 
growth of the fetus and after birth [2]. The placenta 
secretes IGF-1 throughout gestation which 
encourages the transmission of important nutrients 
from the mother to the fetus via the placenta [3]. 
During gestation, fetal circulating IGF-1 increases and 
at term birth, levels of cord serum IGF-1are positively 
related to the size of fetus and fat mass [4]. Fetal 
serum IGF-I constantly increases during last trimester, 
which coincides with the interval of the most rapid 
increase in fetal weight [5]. Late in gestation, 
circulating IGF-1 is mainly derived from the liver, 
although all fetal tissues express IGF-1 from an early 
stage of development [6]. The amniotic fluid contains 
higher IGF-1 concentrations than cord blood during 
gestation and at delivery and is swallowed by the 
fetus, and this source is missing after premature 
delivery [7]. Insulin is the main determinant of fetal 
and neonatal hepatic IGF-1 secretion, and via insulin, 
IGF-1 is magnified by the direct and indirect 
influences of nutrients like glucose and protein. Also, 
insulin reciprocally regulates hepatic production of 
insulin-like growth factor binding protein (IGFBP-1), 
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which in turn inhibits IGF-1 bioactivity [8]. There is 6 
binding proteins (IGFBP) control IGF-1 action. About 
80% of IGF-1 is combined with IGFBP-3 which 
together with an acid-labile subunit maintains a 
reservoir of circulatory IGF-1 [9]. After fasting and 
during hypoxia serum levels of IGFBP-1 increase, 
which restrict growth through lowering the IGF-1 
bioavailability [10]. Mothers’ milk should be advised 
for preterm infants by direct breastfeeding and/or by 
mother's own expressed milk [11]. Some studies on 
Holder pasteurisation have demonstrated partial or 
total inhibition of bioactive components as 
immunological, growth and antioxidant factors. These 
constituents are available in huge quantities in 
preterm infants’ mothers’ milk and are significantly 
essential immediately after delivery [12]. In particular, 
the premature breast milk contains high levels of IGF-
1which are lowered by approximately 40% upon 
Holder pasteurisation [13]. Milk-borne IGF-1 acts as a 
growth factor for intestinal maturation; while, some 
animal researches have demonstrated possible 
absorption into circulation with a dose-dependent 
elevation in orally administered IGF-1 and protective 
action of milk proteins on IGF-1 degradation [14]. 
The current study aimed to evaluate the 
influence of immediate breast milk feeding either 
expressed breast milk (EBM) or direct breastfeeding 
on levels of serum IGF-1in preterm newborns. 
 
 
Subjects and Methods 
 
This is a prospective, longitudinal, 
observational cohort study; included all preterm 
infants of < 32 weeks gestational age admitted into 
neonatal intensive care unit of Children Hospital, 
Faculty of Medicine, Ain Shams University between 
December 2016 and January 2018. The study was 
approved by the medical ethical committee of National 
Research Center, Cairo, Egypt by the code of ethics 
of the world medical association (Declaration of 
Helsinki) for experiments in humans, 1975. Approval 
No. (18113). 
Exclusion criteria were conditions that 
influence IGF-1 plasma levels: intrauterine growth 
retardation, small for gestational age, insulin or steroid 
therapy; also, infants with cerebral lesions or any 
gestational congenital anomaly were excluded. The 
study design and clinical and laboratory assessments 
were explained, and informed consent was obtained 
from parents and/or legal guardians of infants before 
enrolment in the study.  
 Subjects of the study were divided into 2 
groups regarding breast milk intake (direct or 
expressed breast milk) shortly after birth: Group A, 30 
newborns fed on breast milk ≥ 50 mL/Kg/day and 
glucose infusion (10%), without any parenteral 
supplementation with fat or amino acids from the first 
days of life; Group B, 30 infants received glucose 
infusion (10%), plus milk formula without any 
parenteral supplementation with fat or amino acids 
due to insufficient mother’s breast milk or the illness of 
the mother by any condition that prevents normal 
breastfeeding as infection of the mother by HIV or 
Hepatitis B. Parenteral feeding was started on the first 
day of life in all infants with a birth weight < 1250 g. 
Fluid intake was started with 60 mL/Kg/day to 
guarantee sufficient intake of calories (120-130 
Kg/day) [15]. Before administration, the milk bottles 
were shaken to integrate any remains, and the 
needed amount was aseptically separated. Fresh 
breast milk was not given to infants of mothers with 
HIV, HBV, HCV, CMV, typhoid, paratyphoid, 
brucellosis, pertussis, active pulmonary tuberculosis, 
or syphilis, or under medications unsuitable for 
breastfeeding. Also, breastfeeding was interrupted 
temporarily in the case of mastitis, nipple mycosis, 
breast or chest herpes simplex or varicella zoster 
infections. To estimate feeding tolerance, the daily 
gastric residual volume (GRV) and episodes of daily 
emesis were recorded. The criteria for decreasing 
enteral feeding were GRV > 4 mL/Kg after one meal 
or > 2 mL/Kg after 3 consecutive meals, or > 3 
consecutive episodes of vomiting. For a total 
withdrawal of enteral feeding were GRV > 5 mL/Kg 
after one meal, abdominal distension with an increase 
in abdominal circumference > 2 cm in 24 hours, 
metabolic acidosis with pH < 7.20 for > 2 hours, 
hypoxia with paO2 < 50 mm/Hg for > 2 hours, or 
hypotension. Full enteral feeding was defined by an 
intake of 150 mL/kg/day. Total parenteral and enteral 
caloric and protein intakes were calculated. Despite 
the diversity of macronutrients, with breast milk given 
over the first two weeks of life, it was assumed that 
the raw milk energy and protein contents were 78 
kcal/100 mL and 2.2 g/100 mL, respectively [16].  
IGF-I in serum was measured by 
chemiluminescence immunoassay (Liaison, DiaSorin, 
Saluggia, Italy) at 1-2 days postnatal and 40 weeks 
gestational age. The intra-assay coefficient of 
variation is 8% at both 10.3 nmol/l and 17.5 nmol/l and 
9% at 23.8 nmol/l. Inter-assay coefficient of variation 
is 10% at 6.9 nmol/l, 7.4% at 30.8 nmol/l and 16% at 
59.4 nmol/l. 
Standardised measurements of weight, 
length, and head circumference (HC) were recorded 
within the first 24 h after birth and then weekly on the 
same weekday as blood sampling for IGF-I and 
continued until discharge. Most of the growth 
measurements were performed by one examiner. 
Weight was measured on a digital scale (Tanita TL-
150MA, Tanita Corporation, Tokyo, Japan). Crown to 
heel length was measured using a portable length 
scale instrument with increments in millimetres 
developed at the NICU enabling measurements within 
the incubator as on the nursing table. HC was 
measured in the maximum front-occipital plane using 
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an individual non-extensible plastic-coated tape with 
increments in millimetres. Z-score (Standard deviation 
score, SDS) was calculated for all measurements of 
each respective growth parameter. SDS signifies how 
many SD is > or < the mean of a reference population. 
SDS length and SDS HC were computed from a 
gender-specific growth reference in the Egyptian 
population, whereas SDS weight was calculated from 
an intrauterine growth curve based on ultrasonically 
estimated fetal weights in Egypt (17).  
It was done by statistical package for social 
sciences (SPSS) version 21 for Windows (IBM Corp., 
Armonk, NY, USA). Continuous data were expressed 
as mean ± standard deviation and were compared by 
using student’s t-test and paired t-test. Categorical 
data were expressed as numbers and analysed with 
the two-tailed chi-square test. Multiple linear 
regression analysis was done to find predictors of 
serum IGF-1 at birth and at age correspond to 40 
weeks gestational age. P < 0.05 was accepted as 
statistically significant. 
 
 
Results 
 
A group of 70 preterm newborns were 
included in the study. We excluded 6 neonates small 
for gestational age and 4 with cerebral lesions. The 
remaining 60 were divided into 2 groups: group A (N = 
30) fed breast milk either direct or expressed and 
group B (N = 30) receiving formula till the age 
corresponding to 40 weeks of gestation. Table 1 
shows the baseline features of both groups.  
Table 1: Neonatal characteristics of preterm infants in both 
groups 
 Group A (N = 30) Group B (N = 30)  
 Mean ± SD Mean ± SD P 
Gestational age (weeks) 30.13 ± 1.07 30.17 ± 1.02 0.902 
Weight (kg) 1.45 ± 0.25 1.44 ± 0.24 0.813 
Length (cm) 37.43 ± 1.49 37.87 ± 1.55 0.274 
Head circumference (cm) 27.47 ± 1.61 27.22 ± 1.31 0.518 
Weight SDS 0.26 ± 0.55 0.21 ± 0.41 0.700 
Length SDS -0.59 ± 0.47 0.42 ± 0.37 0.122 
Head circumference SDS 0.10 ± 0.65 -0.01 ± 0.50 0.335 
Apgar score (1 minute) 5.04 ± 1.43 5.07 ± 1.36 0.929 
Apgar score (5 minutes) 7.46 ± 0.95 7.46 ± 0.92 0.991 
 No No  
Sex (Male/Female) 10/20 10/20 1.000 
Mode of delivery (CS/SVD) 24/6 25/5 0.739 
P < 0.05 is significant; SDS = Standard deviation score; CS = Cesarean section; SVD = 
Spontaneous vaginal delivery. 
 
No apparent differences were seen in both 
groups as regards gestational age, weight, height, 
head circumference and SDS of height, weight and 
head circumference (p > 0.05). Both groups included 
10 males and 20 females. In group A, 24 were 
delivered by section and 6 by normal labour, while in 
group B, 25 were delivered by section and 5 by 
normal labor with no marked difference among both 
groups (p > 0.05). 
However, mean plasma level of IGF-1in group 
A was not significantly different from that in group B at 
birth (p > 0.05), a significantly higher level of mean 
serum IGF-1 was detected in group A than in Group B 
at age equivalent to 40 weeks of gestation 
measurement (p < 0.05) (Table 2).  
Table 2: IGF-1 in the studied groups at birth and at 40 weeks 
gestational age 
 Group A (n = 30) Group B (n = 30) 
p 
 Mean ± SD Mean ± SD 
IGF-1 at birth 20.13 ± 5.46 20.19 ± 6.21 0.970 
IGF-1 at 40 weeks GA 25.21 ± 6.69 21.11 ± 4.59 0.008* 
*p < 0.05 is significant; GA = Gestational age. 
 
In Table 3, mean serum IGF-1 in each 
separate group was compared at birth and 40 weeks 
GA using a paired t-test. In group A, a higher 
significance level was detected in mean serum IGF-1 
at equivalent 40 weeks of gestation than that at birth 
(p < 0.001) while in group B, no evident difference 
was shown (p > 0.05).  
Table 3: IGF-1 at birth and 40 weeks gestational age in each 
group 
 IGF-1 at birth IGF-1 at 40 weeks GA 
p 
 Mean ± SD Mean ± SD 
Group A (n = 30) 20.13 ± 5.46 25.21 ± 6.69 0.000* 
Group B (n = 30) 20.19 ± 6.21 21.11 ± 4.59 0.111 
*p < 0.05 is significant; GA = Gestational age. 
 
Table 4, and 5 shows the predictors of IGF-1 
as the dependent variable at birth and equivalent 40 
weeks of gestation respectively. At birth, birth weight 
and gestational age were the main predictors of 
serum IGF-1. High birth weight and high gestational 
age were associated with high serum IGF-1 at birth.  
Table 4: Multiple linear regression analysis for the predictors 
of serum IGF-1 at birth 
 
 
Unstandardized 
Coefficients 
Standardised 
Coefficients t P 
 B Std. Error Beta 
Gestational age (weeks) 3.585 1.663 .645 2.156 0.036* 
Weight (kg) 11.557 5.287 0.467 2.186 0.034* 
Length -1.511 0.810 -0.406 -1.867 0.068 
Apgar score 1 min 0.342 0.630 0.078 0.542 0.590 
Apgar score 5 min 1.760 0.956 0.278 1.841 0.072 
*P < 0.05 is significant. 
 
At the age equivalent to 40 weeks of 
gestation, predictors of serum IGF-1 were birth 
weight, gestational age and breastfeeding during the 
early months of postnatal life. Increased birth weight, 
high GA and breastfeeding were accompanied by high 
serum level of IGF-1 at a postnatal age corresponding 
to 40 weeks GA. 
Table 5: Multiple linear regression analysis for the predictors 
of serum IGF-1 at 40 weeks gestational age 
 
 
Unstandardized 
Coefficients 
Standardised 
Coefficients t Sig. 
 B Std. Error Beta 
Gestational age (weeks) 3.560 1.630 0.603 2.184 0.034* 
Weight (kg) 11.396 5.173 0.433 2.203 0.033* 
Length -0.200 0.802 -0.051 -0.249 0.804 
Apgar score 1 min 0.890 0.617 0.191 1.442 0.156 
Apgar score 5 min 0.253 0.936 0.038 0.270 0.788 
Group -4.822 1.501 -0.391 -3.213 0.002* 
*P < 0.05 is significant. 
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Discussion 
 
It is known that fetus ingests significant 
amounts of amniotic fluid during the intrauterine third 
trimester, which contains higher values of IGF-1 than 
cord blood during pregnancy or at delivery. Human 
milk also, particularly colostrum, contains IGF-1. 
Although preterm infants may be fed on maternal 
milk/colostrum, the amounts are often very scanty, 
and maternal expression of colostrum could be 
inconvenient after birth immediately. Therefore, in 
preterm newborns, lack of IGF-1 resources in amniotic 
fluid and colostrum/milk may lead to less IGF-1 levels 
[18]. After very premature delivery, IGF-1 serum 
values decrease significantly to about 10 ng/ml while it 
is about > 50 ng/ml intrauterine at 23 to 30 weeks GA. 
Continuous low levels of IGF-1 after premature 
delivery are shown to be accompanied by a poor 
general and brain development as well as neonatal 
complications as intraventricular haemorrhage, 
retinopathy of prematurity (ROP), bronchopulmonary 
dysplasia (BPD)and necrotising enterocolitis (NEC) 
[19]. Levels of IGF-1were shown to be scanty at time 
of delivery of low birth weight babies, but increased 
gradually over the first 8 weeks of life and were 
positively associated with body weight, body length 
and body mass index at all time points. Also, IGF-I 
was shown to be accompanied by satisfactory growth 
at early postnatal age than by feeding and influence of 
nutrition on values of IGF-I may be limited to the 
period of settled catch-up growth [20]. In the current 
study, mean serum IGF-1 in preterm infants feeding 
breast milk (from birth till age corresponding to 40 
weeks of gestation) was markedly more than that in 
preterm newborns feeding formula milk. Early 
breastfeeding was associated with increased serum 
value of IGF-1in preterm newborns.  
In 2013, de Zegher et al. compared the 
influence of breastfeeding vs formula feeding after 
birth (small for gestational age) on weight and 
endocrine markers in late infancy (at birth, 4 and 12 
months) [22]. In contrast to the results of our study, 
they found that formula-fed infants had increased 
adiposity and higher IGF-I values than breastfed 
babies. That can be explained by the difference in the 
age at which IGF-1 was measured, and type of infants 
included in the study at birth at an age corresponding 
to 40 weeks of gestation and premature infants in the 
present study [21], [22]. Hansen-Pupp et al., 2011 
studied the interaction between feeding, IGF-I, and 
growth in 64 of premature infants. They concluded 
that IGF-I is related to growth at an earlier postnatal 
age more than feeding and influence of feeding on 
IGF-I levels may be limited to the phase of settled 
catch up growth [23]. Giapros et al., 2012 investigated 
in a prospective study the 1
st
 year of life’s IGF serum 
levels in 112 premature babies born equivalent to 32-
36 weeks of gestation and their correlation with weight 
at birth and early neonatal growth. The average 
values of IGF-I at 2 and 6 weeks, was shown to be 82 
± 44, 100 ± 31 ng/ml, respectively [24]. In the current 
study, mean serum IGF-1, at the start and end point 
was 20.13 ± 5.46 and 25.21 ± 6.69 in group A 
respectively which were below than that in Giapros et 
al. ’s results. That can be explained by the difference 
in GA of preterm babies enrolled at the start point of 
both studies [24]. 
Serrao et al., 2016 studied 52 premature 
newborns with GA < 31 weeks. They were divided into 
two groups as regards intake of expressed breast milk 
(< or ≥ 50 mL/Kg/day) till 32 weeks of gestation when 
sampling of blood for IGF-1 analysis was performed. 
In contrast to our study, they found that early 
expressed breast milk did not influence IGF-1 plasma 
values in preterm newborns [25]. The difference in 
results could be explained by the end point of 
measurement of IGF-1 which was 32 weeks of 
gestation in their study and 40 weeks of gestation in 
our study. 
In conclusion, early breast milk nutrition, 
either expressed or direct feeding was correlated with 
a high serum IGF-1 in premature babies who may act 
to diminish general growth abnormalities, metabolic 
disorders, lung and retinal immaturity and brain 
developmental abnormalities which results in 
abnormalities in cognitive function. This study 
encourages maximum efforts to support immediate 
breast milk nutrition in the neonatal intensive care 
unit. 
Further clinical trials are needed to study 
pitfalls and advantages of IGF-1 replacement in very 
premature newborns to keep postnatal IGF-1 to near 
fetal levels. 
The essential restriction of this study is a 
small number of infants. The results have to be 
confirmed in larger groups of preterm infants to 
ensure high statistical power. Second, the study 
recruited subjects born in one hospital, and this limited 
sample makes it hard to be generalised on other 
populations. Finally, residual confounding factors not 
measured in our study may have affected the 
correlation between breastfeeding and IGF-1.  
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